Does LEVOMILNACIPRAN Cause Type 2 diabetes mellitus? 144 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Type 2 diabetes mellitus have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 10.5% of all adverse event reports for LEVOMILNACIPRAN.
144
Reports of Type 2 diabetes mellitus with LEVOMILNACIPRAN
10.5%
of all LEVOMILNACIPRAN reports
144
Deaths
93
Hospitalizations
How Dangerous Is Type 2 diabetes mellitus From LEVOMILNACIPRAN?
Of the 144 reports, 144 (100.0%) resulted in death, 93 (64.6%) required hospitalization, and 94 (65.3%) were considered life-threatening.
Is Type 2 diabetes mellitus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Type 2 diabetes mellitus?
ATORVASTATIN (7,556)
ADALIMUMAB (3,516)
PREDNISONE (3,484)
METHOTREXATE (3,465)
RITUXIMAB (3,318)
TOCILIZUMAB (3,145)
ABATACEPT (3,074)
LEFLUNOMIDE (3,033)
ALENDRONATE (3,002)
DICLOFENAC (2,974)
Which LEVOMILNACIPRAN Alternatives Have Lower Type 2 diabetes mellitus Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE